An Antiestrogenic Activity Score for tamoxifen and its metabolites is associated with breast cancer outcome

PURPOSE: Endoxifen concentrations have been associated with breast cancer recurrence in tamoxifen-treated patients. However, tamoxifen itself and other metabolites also show antiestrogenic anti-tumor activity. Therefore, the aim of this study was to develop a comprehensive Antiestrogenic Activity Sc...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Breast Cancer Res Treat
Glavni autori: de Vries Schultink, A. H. M., Alexi, X., van Werkhoven, E., Madlensky, L., Natarajan, L., Flatt, S. W., Zwart, W., Linn, S. C., Parker, B. A., Wu, A. H. B., Pierce, J. P., Huitema, A. D. R., Beijnen, J. H.
Format: Artigo
Jezik:Inglês
Izdano: 2016
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5812686/
https://ncbi.nlm.nih.gov/pubmed/28005246
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-016-4083-6
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items